Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany; DZHK (German Centre for Cardiovascular Research), partner site Rhein-Main, Frankfurt am Main, Germany; Kerckhoff Heart Center, Department of Cardiac Surgery, Bad Nauheim, Germany; Justus-Liebig University of Giessen, Department of Cardiology, Giessen, Germany.
Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany; DZHK (German Centre for Cardiovascular Research), partner site Rhein-Main, Frankfurt am Main, Germany; Kerckhoff Heart Center, Department of Cardiac Surgery, Bad Nauheim, Germany.
Int J Cardiol. 2018 Jul 15;263:171-176. doi: 10.1016/j.ijcard.2018.02.042.
The extent of aortic valve calcification is an important determinant of procedural success in transcatheter aortic valve implantation (TAVI). We sought to validate device landing zone calcium volume (DLZ-CV) measurements on contrast-enhanced multidetector computed tomography (MDCT) with non-contrast-enhanced scans as reference.
We determined DLZ-CV in 141 patients undergoing transfemoral TAVI. Non-contrast-enhanced images were analyzed using a threshold of 130 HU as reference (DLZ-CV). For contrast-enhanced scans, we applied various thresholds including 450 HU (DLZ-CV), 850 HU (DLZ-CV), mean aortic attenuation (Atten) + 2 SD (DLZ-CV), Atten + 4 SD (DLZ-CV), Atten + 4 SD + 5 mm volume filter (DLZ-CV), and based on visual estimation (DLZ-CV). We compared DLZ-CV values between patients with versus without paravalvular leak (PVL), and between patients with versus without post-dilatation stratified by the type of prosthesis.
All DLZ-CV measurements on contrast-enhanced scans significantly differed from DLZ-CV (p < 0.001 for all comparisons). The best approximation to DLZ-CV was achieved with DLZ-CV (508 mm [332-772]; Pearson correlation: R = 0.87, p < 0.001; Bland-Altman: mean difference 1339 mm [limits of agreement 79;2600]). Moreover, DLZ-CV allowed for discrimination of PVL ≥1° or the need for post-dilatation in patients receiving self-expanding prostheses. Procedural outcome using balloon-expandable prostheses was independent of DLZ-CV.
Measurement of DLZ-CV using contrast-enhanced scans with unadjusted thresholds results in incorrect estimation of the calcium volume. The use of a scan-specific individual HU threshold including a volume filter (DLZ-CV) provides the best approximation to the reference and allows for discrimination of PVL ≥ 1° in patients receiving the Acurate neo prosthesis.
主动脉瓣钙化程度是经导管主动脉瓣植入术(TAVI)成功的重要决定因素。我们试图通过以非增强扫描为参考的对比增强多排 CT(MDCT)来验证设备着陆区钙体积(DLZ-CV)的测量。
我们在 141 名接受经股 TAVI 的患者中确定了 DLZ-CV。使用 130 HU 的阈值作为参考(DLZ-CV)来分析非增强图像。对于增强扫描,我们应用了各种阈值,包括 450 HU(DLZ-CV)、850 HU(DLZ-CV)、平均主动脉衰减(Atten)+2 SD(DLZ-CV)、Atten+4 SD(DLZ-CV)、Atten+4 SD+5mm 体积过滤器(DLZ-CV)和基于视觉估计(DLZ-CV)。我们比较了有/无瓣周漏(PVL)患者之间以及根据假体类型分层的有/无后扩张患者之间的 DLZ-CV 值。
所有增强扫描的 DLZ-CV 测量值均与 DLZ-CV 有显著差异(所有比较的 p<0.001)。与 DLZ-CV 最接近的是 DLZ-CV(508mm[332-772];Pearson 相关:R=0.87,p<0.001;Bland-Altman:平均差值 1339mm[一致性界限 79;2600])。此外,DLZ-CV 可区分接受自膨式假体的患者中≥1 级的 PVL 或需要后扩张。使用球囊扩张式假体的程序结果与 DLZ-CV 无关。
使用未经调整的阈值的增强扫描测量 DLZ-CV 会导致钙体积的错误估计。使用包括体积过滤器的特定于扫描的个体 HU 阈值(DLZ-CV)可提供对参考的最佳逼近,并可区分接受 Accurate neo 假体的患者中≥1 级的 PVL。